Cue Biopharma Inc buy Stifel Nicolaus
Start price
09.04.24
/
50%
€1.65
Target price
09.04.25
€7.35
Performance (%)
-13.33%
Price
14.05.24
€1.43
Summary
This prediction is currently active. The prediction for Cue Biopharma Inc disappoints with a performance of -13.33%. This prediction currently runs until 09.04.25. The prediction end date can be changed by Stifel_Nicolaus at any time. Stifel_Nicolaus has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Cue Biopharma Inc | -20.112% | -20.112% |
iShares Core DAX® | 1.851% | 5.158% |
iShares Nasdaq 100 | 1.573% | 2.589% |
iShares Nikkei 225® | -0.412% | -2.857% |
iShares S&P 500 | 1.128% | 2.485% |
Comments by Stifel_Nicolaus for this prediction
In the thread Cue Biopharma Inc diskutieren
Cue Biopharma, Inc. (NASDAQ: CUE) had its "buy" rating re-affirmed by analysts at Stifel Nicolaus. They now have a $8.00 price target on the stock.
Ratings data for CUE provided by MarketBeat